Can’t find what you’re looking for? Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Order Online! Now! Get your $50 coupon for online order. 
Order Online! Now! Get your $50 coupon for online order.
Get your basement membrane extract free sample to test now! Get your basement membrane extract free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ALG-H52E1 | Human | Biotinylated Human ALPG / ALPPL2 Protein, His,Avitag™ (MALS verified) |  |
|
|
| ALG-M52H9 | Mouse | Mouse ALPG / ALPPL2 Protein, His Tag (MALS verified) |  |
|
|
| ALG-H52H9 | Human | Human ALPG / ALPPL2 Protein, His Tag (MALS verified) |  |
|
|
Immobilized Human ALPG, His Tag (Cat. No. ALG-H52H9) at 1 μg/mL (100 μL/well) can bind Anti - ALPG / ALPPL2 with a linear range of 0.002-0.125 μg/mL (QC tested).
The purity of Biotinylated Human ALPG Protein, His,Avitag (Cat. No. ALG-H52E1) is more than 90% and the molecular weight of this protein is around 115-135kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Amifostine | NSC-296961; YM-08310; S-8744; SAPEP; WR-2721; WR-2721C | Approved | Medimmune Llc | 天地达, 安福定, Ethyol | United States | Cytoprotective adjuvant | China Grand Automotive Services Group Co Ltd | 1995-12-08 | Cytoprotective adjuvant; Myelodysplastic-Myeloproliferative Diseases; Lymphoma, Non-Hodgkin; Lymphoma; Lung Neoplasms; Salivary Gland Diseases; Mucositis; Bone Marrow Diseases; Acute Radiation Syndrome; Breast Neoplasms; Sarcoma; Prostatic Neoplasms; Radiation Injuries; Head and Neck Neoplasms; Gestational Trophoblastic Disease; Fanconi Anemia; Hodgkin Disease; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Neutropenia; Carcinoma; Trigeminal Neuralgia; Solid tumours; Ovarian Neoplasms; Peripheral Nervous System Diseases; Drug-Related Side Effects and Adverse Reactions | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ALXN-1850 | ALXN-1850 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
This web search service is supported by Google Inc.
A-Z
